Margaret Kaczor
Stock Analyst at William Blair
(0.45)
# 3,027
Out of 4,479 analysts
21
Total ratings
40%
Success rate
-13.85%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STIM Neuronetics | Upgrades: Outperform | n/a | $1.75 | - | 2 | May 14, 2024 | |
| CVRX CVRx, Inc. | Downgrades: Market Perform | n/a | $11.78 | - | 2 | May 1, 2024 | |
| CUTR Cutera | Upgrades: Market Perform | n/a | $1.35 | - | 3 | Mar 22, 2024 | |
| INGN Inogen | Upgrades: Outperform | n/a | $7.67 | - | 4 | Feb 15, 2024 | |
| SKIN The Beauty Health Company | Downgrades: Market Perform | n/a | $1.96 | - | 2 | Nov 14, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Market Perform | n/a | $44.52 | - | 1 | Jun 7, 2023 | |
| VAPO Vapotherm | Downgrades: Market Perform | n/a | $2.10 | - | 1 | Aug 4, 2022 | |
| NVRO Nevro | Downgrades: Market Perform | n/a | $8.35 | - | 1 | Aug 5, 2021 | |
| AFIB Acutus Medical | Downgrades: Market Perform | n/a | $0.04 | - | 1 | Mar 19, 2021 | |
| DVA DaVita | Assumes: Outperform | n/a | $138.45 | - | 1 | Jun 6, 2018 | |
| MDT Medtronic | Assumes: Market Perform | n/a | $77.37 | - | 1 | Jun 6, 2018 | |
| ABT Abbott Laboratories | Upgrades: Outperform | n/a | $103.20 | - | 1 | Jan 25, 2018 | |
| DXCM DexCom | Initiates: Outperform | n/a | $112.49 | - | 1 | Apr 27, 2017 |
Neuronetics
May 14, 2024
Upgrades: Outperform
Price Target: n/a
Current: $1.75
Upside: -
CVRx, Inc.
May 1, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $11.78
Upside: -
Cutera
Mar 22, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $1.35
Upside: -
Inogen
Feb 15, 2024
Upgrades: Outperform
Price Target: n/a
Current: $7.67
Upside: -
The Beauty Health Company
Nov 14, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.96
Upside: -
STAAR Surgical Company
Jun 7, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $44.52
Upside: -
Vapotherm
Aug 4, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $2.10
Upside: -
Nevro
Aug 5, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $8.35
Upside: -
Acutus Medical
Mar 19, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $0.04
Upside: -
DaVita
Jun 6, 2018
Assumes: Outperform
Price Target: n/a
Current: $138.45
Upside: -
Medtronic
Jun 6, 2018
Assumes: Market Perform
Price Target: n/a
Current: $77.37
Upside: -
Abbott Laboratories
Jan 25, 2018
Upgrades: Outperform
Price Target: n/a
Current: $103.20
Upside: -
DexCom
Apr 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $112.49
Upside: -